Abdominal Aortic Aneurysm Clinical Trials 2023

Abdominal Aortic Aneurysm Clinical Trials 2023

Abdominal Aortic Aneurysm research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in abdominal aortic aneurysm clinical trials today.

Trials for AAA Patients

Trials for Aortic Aneurysm Patients

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to abdominal aortic aneurysm

What are the top hospitals conducting abdominal aortic aneurysm research?

Advancements in medical research continue to revolutionize the treatment of abdominal aortic aneurysm, and several top hospitals are leading the charge. In Boston, Massachusetts General Hospital is at the forefront with two ongoing clinical trials dedicated to this condition. Over the years, they have conducted a remarkable 12 trials focusing on abdominal aortic aneurysms since their first recorded trial in 2005. Meanwhile, in Grand Rapids, Spectrum Health System has emerged as another prominent institution addressing this health issue. They currently have two active trials and have contributed to three previous studies since initiating their first trial in 2011.

Further down south, Mission Hospital located in Asheville has also made significant contributions by conducting five total abdominal aortic aneurysm trials thus far while having just begun their journey into researching this condition back in 2010. Not to be outdone, Cleveland Clinic Foundation has been actively involved with six past investigations related to abdominal aortic aneurysms following its inception of undertaking such tests starting from year2005; meanwhile maintaining current involvement through two active ongoing ones for better understanding of it's intricate workings.

Lastly but not least University of Pittsburgh Medical Center based hospital sets itself apart as well by embarking on eight separate explorations regarding these types after kicking off such projects way back right same year when Cleveland began theirs whose present status still holds strong through participation within two different recent experiments.

These hospitals represent pillars of innovation and expertise when it comes to tackling abdominal aortic aneurysms head-on. Through collective efforts and tireless dedication towards groundbreaking clinical trials, researchers strive toward improving outcomes for individuals affected by this potentially life-threatening condition that affects the large blood vessel supplying oxygenated blood to our vital organs situated deep within our abdomen including kidneys liver intestines etc., making them emblematic examples pushing boundaries towards transforming medical landscape positively

Which are the best cities for abdominal aortic aneurysm clinical trials?

When it comes to abdominal aortic aneurysm clinical trials, several cities emerge as key players in advancing research and treatment options. Among them are Birmingham, Alabama; Phoenix, Arizona; Sioux Falls, South dakota; Houston, Texas; and Boston Massachusetts. Each of these cities currently hosts multiple active trials focused on innovative interventions such as the GORE® EXCLUDER® Conformable AAA Endoprosthesis and the Treovance stent-graft. With their commitment to cutting-edge research and advancements in care, these cities provide individuals with abdominal aortic aneurysms access to potential breakthrough treatments that can improve outcomes and quality of life.

Which are the top treatments for abdominal aortic aneurysm being explored in clinical trials?

Abdominal aortic aneurysm clinical trials are exploring several innovative treatments to combat this condition. Among the top contenders is Multimodal Prehabilitation, currently being tested in one active trial since its first listing in 2023. Another promising option is the Physician-Modified Cook Zenith Alpha Thoracic Endovascular Graft, which has also caught attention with one ongoing trial and was first listed in 2021. Additionally, researchers are investigating the potential of the GORE® EXCLUDER® Conformable AAA Endoprosthesis, which made its debut in 2017 and is currently under evaluation in one active abdominal aortic aneurysm trial. With these novel approaches on the horizon, there is hope for improved outcomes for individuals grappling with abdominal aortic aneurysms.

What are the most recent clinical trials for abdominal aortic aneurysm?

Exciting advancements in the field of abdominal aortic aneurysm research offer hope for patients diagnosed with this condition. One recent clinical trial focuses on evaluating the effectiveness of the Treovance stent-graft as a potential treatment option. This innovative Phase 2 study, available since 11/23/2013, aims to assess the outcomes and safety profile associated with using this device in individuals with abdominal aortic aneurysms. Additionally, another significant Phase 3 trial conducted since 9/1/2006 examines various treatments for abdominal aortic aneurysm, aiming to enhance patient care and ultimately improve long-term prognosis. These groundbreaking trials contribute valuable insights that may shape future treatment approaches for individuals affected by abdominal aortic aneurysms.

What abdominal aortic aneurysm clinical trials were recently completed?

Several noteworthy clinical trials focusing on abdominal aortic aneurysm have recently concluded, presenting advancements in the management of this condition. In October 2021, a trial sponsored by the University Hospitals Cleveland Medical Center investigated the effectiveness of endovascular repair techniques. Another study led by Johns Hopkins Medicine examined biomarkers for risk assessment and was completed in September 2021. Additionally, a trial exploring innovative imaging modalities to enhance diagnosis and monitoring reached completion in January 2021. These recent achievements shed light on ongoing efforts to improve treatment options and patient outcomes for individuals with abdominal aortic aneurysms.